Tags

Type your tag names separated by a space and hit enter

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
Am J Gastroenterol. 2003 Jul; 98(7):1563-8.AJ

Abstract

OBJECTIVE

Previous studies of complementary and alternative medicine (CAM) use by patients with inflammatory bowel disease (IBD) have relied on samples from specialty clinics. The aim of this study was to determine the prevalence of use and perceived outcomes of CAM in a large, diverse IBD population.

METHODS

A postal survey of the members of the Crohn's and Colitis Foundation of Canada gathered data on demographic, disease, and conventional IBD treatment characteristics, and on the use and perceived effects of CAM. Respondents were characterized as not using CAM, as past or present users of CAM for their IBD, or as present users of CAM for other reasons. Comparisons between groups were made with the chi(2) test.

RESULTS

The final sample included 2847 IBD patients. Current or past use of CAM for IBD was reported by 1332 patients, of whom 666 continued their use of CAM. Use was lowest in the eastern provinces and highest in the west. Only 15% had used CAM before their IBD diagnosis. Herbal therapies were the most commonly used (41% of CAM users). Improvements in sense of well-being, IBD symptoms, and sense of control over the disease were the most commonly reported benefits. Only 16% of prior CAM users reported any adverse effect of CAM use. A complementary practitioner was consulted by 34%. During the previous year, 46% had spend more than $250 on CAM.

CONCLUSIONS

Use of CAM by IBD patients is very common. Most of these patients attribute significant benefits to their CAM use. Few report significant adverse events.

Authors+Show Affiliations

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12873578

Citation

Hilsden, Robert J., et al. "Complementary and Alternative Medicine Use By Canadian Patients With Inflammatory Bowel Disease: Results From a National Survey." The American Journal of Gastroenterology, vol. 98, no. 7, 2003, pp. 1563-8.
Hilsden RJ, Verhoef MJ, Best A, et al. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol. 2003;98(7):1563-8.
Hilsden, R. J., Verhoef, M. J., Best, A., & Pocobelli, G. (2003). Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. The American Journal of Gastroenterology, 98(7), 1563-8.
Hilsden RJ, et al. Complementary and Alternative Medicine Use By Canadian Patients With Inflammatory Bowel Disease: Results From a National Survey. Am J Gastroenterol. 2003;98(7):1563-8. PubMed PMID: 12873578.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. AU - Hilsden,Robert J, AU - Verhoef,Marja J, AU - Best,Allan, AU - Pocobelli,Gaia, PY - 2003/7/23/pubmed PY - 2003/9/5/medline PY - 2003/7/23/entrez SP - 1563 EP - 8 JF - The American journal of gastroenterology JO - Am J Gastroenterol VL - 98 IS - 7 N2 - OBJECTIVE: Previous studies of complementary and alternative medicine (CAM) use by patients with inflammatory bowel disease (IBD) have relied on samples from specialty clinics. The aim of this study was to determine the prevalence of use and perceived outcomes of CAM in a large, diverse IBD population. METHODS: A postal survey of the members of the Crohn's and Colitis Foundation of Canada gathered data on demographic, disease, and conventional IBD treatment characteristics, and on the use and perceived effects of CAM. Respondents were characterized as not using CAM, as past or present users of CAM for their IBD, or as present users of CAM for other reasons. Comparisons between groups were made with the chi(2) test. RESULTS: The final sample included 2847 IBD patients. Current or past use of CAM for IBD was reported by 1332 patients, of whom 666 continued their use of CAM. Use was lowest in the eastern provinces and highest in the west. Only 15% had used CAM before their IBD diagnosis. Herbal therapies were the most commonly used (41% of CAM users). Improvements in sense of well-being, IBD symptoms, and sense of control over the disease were the most commonly reported benefits. Only 16% of prior CAM users reported any adverse effect of CAM use. A complementary practitioner was consulted by 34%. During the previous year, 46% had spend more than $250 on CAM. CONCLUSIONS: Use of CAM by IBD patients is very common. Most of these patients attribute significant benefits to their CAM use. Few report significant adverse events. SN - 0002-9270 UR - https://www.unboundmedicine.com/medline/citation/12873578/Complementary_and_alternative_medicine_use_by_Canadian_patients_with_inflammatory_bowel_disease:_results_from_a_national_survey_ L2 - https://Insights.ovid.com/pubmed?pmid=12873578 DB - PRIME DP - Unbound Medicine ER -